
Lintitript (SR 27897) is a highly мощный, селективный, orally active, competitive and non-peptide cholecystokinin (CCK1) рецептор антагонист with an EC50 of 6 nM and a Ki of 0.2 nM. Lintitript displays > 33-fold selectivity more селективный for CCK1 than CCK2 receptors (EC50 value of 200 nM). Lintitript increases plasma concentration of leptin and food intake as well as plasma concentration of insulin.
Lintitript (SR 27897) is a highly potent, selective, orally active, competitive and non-peptide cholecystokinin (CCK1) receptor antagonist with an EC50 of 6 nM and a Ki of 0.2 nM. Lintitript displays > 33-fold selectivity more selective for CCK1 than CCK2 receptors (EC50 value of 200 nM). Lintitript increases plasma concentration of leptin and food intake as well as plasma concentration of insulin.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.